The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 2 , Pages 289-294 , August 2009

POINT: Operative risk of pneumonectomy—Influence of preoperative induction therapy

Received 12 May 2008 ,Revised 1 October 2008 ,Accepted 15 November 2008.

References 

  1. Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT, Weick JK, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol. 1995;13:1880–1892
  2. Choi NC, Carey RW, Daley W, Mathisen D, Wain J, Wright C, et al. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol. 1997;15:712–722
  3. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;111:1710–1717
  4. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41–55
  5. Leo F, Solli P, Veronesi G, Radice D, Floridi A, Gasparri R, et al. Does chemotherapy increase the risk of respiratory complications after pneumonectomy?. J Thorac Cardiovasc Surg. 2006;132:519–523
  6. Perrot E, Guibert B, Mulsant P, Blandin S, Arnaud I, Roy P, et al. Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection. Ann Thorac Surg. 2005;80:423–427
  7. Mansour Z, Kochetkova EA, Ducrocq X, Vasilescu MD, Maxant G, Buggenhout A, et al. Induction chemotherapy does not increase the operative risk of pneumonectomy. Eur J Cardiothorac Surg. 2007;31:181–185
  8. Doddoli C, Barlesi F, Trousse D, Robitail S, Yena S, Astoul P, et al. One hundred consecutive pneumonectomies after induction therapy for non–small cell lung cancer: an uncertain balance between risks and benefits. J Thorac Cardiovasc Surg. 2005;130:416–425
  9. Cerfolio RJ, Bryant AS, Spencer SA, Bartolucci AA. Pulmonary resection after high-dose and low-dose chest irradiation. Ann Thorac Surg. 2005;80:1224–1230
  10. Martin J, Ginsberg RJ, Abolhoda A, Bains MS, Downey RJ, Korst RJ, et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg. 2001;72:1149–1154
  11. Boffa DJ, Allen MS, Grab JD, Gaissert HA, Harpole DH, Wright CD. Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg. 2008;135:247–254
  12. Albain KS, Scott CB, Rusch VR, et al. Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA (pN2) non–small-cell lung cancer (NSCLC): initial results from the intergroup trial 0139 (RTOG 9309). Proc Am Soc Clin Oncol. 2003;22:621;(abstr 2497)
  13. Darling GE, Abdurahman A, Yi QL, Johnston M, Waddell TK, Pierre A, et al. Risk of a right pneumonectomy: role of bronchopleural fistula. Ann Thorac Surg. 2005;79:433–437
  14. Gaissert HA, Mathisen DJ, Moncure AC, Hilgenberg AD, Grillo HC, Wain JC. Survival and function after sleeve lobectomy for lung cancer. J Thorac Cardiovasc Surg. 1996;111:948–953
  15. Deslauriers J, Grégoire J, Jacques LF, Piraux M, Guojin L, Lacasse Y. Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences. Ann Thorac Surg. 2004;77:1152–1156
  16. Daly BD, Fernando HC, Ketchedjian A, Dipetrillo TA, Kachnic LA, Morelli DM, et al. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer. Ann Thorac Surg. 2006;82:227–231
  17. Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, et al. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Ann Thorac Surg. 2004;78:1200–1205
  18. Meguid RA, Brooke BS, Chang DC, Sherwood JT, Brock MV, Yang SC. Are surgical outcomes for lung cancer resections improved at teaching hospitals?. Ann Thorac Surg. 2008;85:1015–1024
  19. Finlayson EV, Goodney PP, Birkmeyer JD. Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg. 2003;138:721–725
  20. Mizushima Y, Noto H, Sugiyama S, Kusajima Y, Yamashita R, Kashii T, et al. Survival and prognosis after pneumonectomy for lung cancer in the elderly. Ann Thorac Surg. 1997;64:193–198

 Read at the Eighty-eighth Annual Meeting of The American Association for Thoracic Surgery, San Diego, Calif, May 10–14, 2008. Presented as part of the Point/Counterpoint Session in General Thoracic Surgery.

PII: S0022-5223(09)00509-1

doi: 10.1016/j.jtcvs.2008.11.069

The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 2 , Pages 289-294 , August 2009

Article Tools

* Image Usage & Resolution